English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Nuvation Bio (NUVB.US)$ Reuters· just1min
U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced Ros1-Positive Non-Small Cell Lung Cancer! June 23, 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3381 Views
Comment
Sign in to post a comment
    5169
    Followers
    23
    Following
    74K
    Visitors
    Follow